Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement with a multi-billion biotherapeutics company to enhance the manufacturing process of one of their candidate protein drugs. Per the update,…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies have entered into a 10-year Joint Manufacturing Partnership (“JMP”) to produce DehydraTECH(TM) commercial products under a new brand, which will…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations in 190,000 sq. ft of licensed nursery infrastructure. In addition, the company plans to ramp up its entire 1.3 million…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach…
INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s disease has long been established. Until present, however, this link and the way in which…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company, this morning announced entry of its wholly owned subsidiary, Khrysos Industries, into a one year supply and processing agreement to produce water soluble CBD Isolate, which contains no THC and is expected to generate revenues of $19 million. According to the update, shipping under the agreement…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently named Alan R. Applonie as general manager of its Modesto facility (http://ibn.fm/ndEOZ). A recent article discussing the company reads, “The appointment was made after screening of top-tier talent from the industry for a period of six months. Applonie most recently oversaw a major consumer-goods facility that generated approximately $300…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM) can deliver eight times more CBD into the blood and 19 times more CBD into the brain tissue than standard industry formulations (http://ibn.fm/5y9TR). An article discussing the company reads,…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was prominently featured at a three-day, internationally-attended scientific conference held at the elite Westlake University in Hangzhou, China. Professor Tiannan Guo,…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning released its financial results for the three and twelve months ended March 31, 2019. Audited consolidated financial statements for Canopy Rivers for the twelve months ended March 31, 2019, as well as its full Management’s Discussion and Analysis (the “MD&A”) for the three and twelve months ended…
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its financial results for its fiscal third quarter ended May 31, 2019. “We continued to report strong sales in our third quarter and now have distribution in all ten provinces,” Organigram CEO Greg Engel said…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its receipt of a purchase order from American Eagle Outfitters, Inc. (NYSE: AEO), through which it will sell hemp-derived cannabidiol (“CBD”) infused personal care products in nearly 500 American Eagle stores and online. According to the update, the purchase order represents GGB’s third…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to Universal Hemp LLC. Under the agreement, Universal Hemp, a B2B manufacturer of high-performing hemp-derived bulk ingredients to the consumer packaged…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages L.L.C. Under the agreement, Lexaria will provide its patented DehydraTECH(TM) technology for use in Nic’s CBD-based beverages to be produced and sold throughout…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced that its portfolio company, YSS Corp. (TSXV: YSS) (WKN: A2PMAX), has received five cannabis retail licenses from the Alberta Gaming, Liquor and Cannabis Commission (“AGLC”). Per the update, the five new licenses will operate under the YSS(TM) brand name and are located throughout Alberta. “YSS has…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, this morning announced a collaboration with Lift & Co. Corp. (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Lift & Co.’s CannSell retail training program. As Canada’s first branded cannabis educational program, CannSell’s retail certification program…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its entry into a securities acquisition and contribution agreement, dated as of July 8, 2019, with, among others, MXY Holdings LLC (“Moxie”). Per the update, a new Ontario limited partnership will be formed, of which GGB will be the general partner (“GGB LP”),…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, on Monday announced that it has developed a proprietary nano-emulsification technology for the production of both liquid and powdered cannabinoid products in anticipation of Canada’s legalization of adult use recreational cannabis edibles and consumer demand for cannabis-infused…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) received an amendment to its Health Canada license permitting the sale of cannabis oils from its Mississauga, Ontario facility. Sales of TerrAscend’s cannabis oils are set to commence immediately through its medical marketplace, Solace Health. “With…